磷脂酸磷酸酶LPIN3抗體,Anti-Lipin 3抗體簡(jiǎn)單介紹：

產(chǎn)品編號(hào)：BYK-18291R

英文名稱：Anti-Lipin 3
中文名稱：磷脂酸磷酸酶LPIN3抗體

別名：dJ450M14.2; dJ450M14.3; dJ620E11.2; Lipin 3 like; Lipin-3; Lipin-3-like; Lipin3; LIPN3L; LPIN 3; LPIN3; LPIN3_HUMAN; Phosphatidate phosphatase LPIN3; RP4 620E11.3; SMP2.

背景介紹：Humans lipodystrophy is characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Mice carrying mutations in the fatty liver dystrophy (fld) gene have similar phenotypes. Through positional cloning, the mouse gene responsible for fatty liver dystrophy was isolated and designated Lpin1. The nuclear protein encoded by Lpin1 was named lipin. Lpin1 mRNA was expressed at high levels in adipose tissue and was induced during differentiation of preadipocytes. These results indicated that lipin is required for normal adipose tissue development and provided a candidate gene for human lipodystrophy. Through database searches, mouse and human EST and genomic sequences with similarities to Lpin1 were identified. These included two related mouse genes (Lpin2 and Lpin3) and three human homologs (LPIN1, LPIN2, and LPIN3). Human LPIN1 gene has been mapped to 2p25.; linkages of fat mass and serum leptin levels to this same region have been noted. Human LPIN2 and LPIN3 mapped to chromosomes 18p11 and 20q11-q12, respectively. The mouse genes encoding Lpin1, Lpin2, and Lpin3 mapped to chromosome 12, 17, and 2, respectively.

產(chǎn)品規(guī)格：50ul；100ul；200ul；1ml，*

抗體來(lái)源 Rabbit or Mouse

克隆類型 Polyclonal or Monoclonal

交叉反應(yīng)、產(chǎn)品應(yīng)用 （具體交叉反應(yīng)與產(chǎn)品應(yīng)用請(qǐng)或添加客服直接索?。?/span>

性    狀 Lyophilized or Liquid
濃    度 1mg/ml

磷脂酸磷酸酶LPIN3抗體,Anti-Lipin 3抗體產(chǎn)品信息：

免疫應(yīng)答

    抗原刺激機(jī)體產(chǎn)生相應(yīng)的抗體，抗體的產(chǎn)生過(guò)程即為體液免疫應(yīng)答過(guò)程。

    體液免疫應(yīng)答的主要*位是淋巴結(jié)、脾臟和粘膜下淋巴組織等外周免疫器官，外來(lái)抗原進(jìn)入機(jī)體后即被補(bǔ)體致敏或者被DC吞噬，然后隨淋巴液進(jìn)入引流淋巴結(jié)。淋巴濾泡中的FDC通過(guò)其表面的補(bǔ)體受體捕獲被致敏的外來(lái)抗原，激活B細(xì)胞。位于脾髓質(zhì)交界區(qū)的DC則為T細(xì)胞呈遞外來(lái)抗原肽，啟動(dòng)獲得性免疫應(yīng)答，B細(xì)胞在外周成熟、發(fā)育過(guò)程的zui后階段是成為專門的合成和分泌抗體分子的漿細(xì)胞。漿細(xì)胞高爾基體發(fā)達(dá)、代謝活躍，但沒(méi)有繼續(xù)分裂、增殖的能力，也不參與抗原遞呈。他們寄居在脾臟或者骨髓中，集中所有的能量生產(chǎn)并分泌抗體分子?？贵w分子的重鏈和輕鏈在內(nèi)質(zhì)網(wǎng)上合成、組裝后經(jīng)高爾基體運(yùn)輸至細(xì)胞表面并分泌于胞外。一個(gè)漿細(xì)胞每秒鐘能分泌5000個(gè)抗體分子，在外周的漿細(xì)胞壽命僅為幾天，但是骨髓中的漿細(xì)胞壽命可能較長(zhǎng)。

免疫應(yīng)答過(guò)程：

1.抗原進(jìn)入機(jī)體；

2.抗原刺激 B淋巴細(xì)胞，使之分化增殖成為抗體分泌漿細(xì)胞和記憶細(xì)胞（初次免疫應(yīng)答）；

3.抗體主要由漿細(xì)胞分泌 ；

4.記憶細(xì)胞再次受到特異性抗原刺激后會(huì)被激活而成為分泌抗體的漿細(xì)胞（再次免疫應(yīng)答）；

5.記憶B細(xì)胞是長(zhǎng)命細(xì)胞，可以存活數(shù)月甚至機(jī)體終生

磷脂酸磷酸酶LPIN3抗體,Anti-Lipin 3抗體相關(guān)產(chǎn)品：

Anti-VEGF-B 血管內(nèi)皮生長(zhǎng)因子B抗體
Anti-NRSN1 神經(jīng)囊泡膜蛋白1抗體
Anti-VEGF-C 血管內(nèi)皮生長(zhǎng)因子C型抗體
Anti-ICA12/SOX13 胰島細(xì)胞抗原12/核轉(zhuǎn)錄因子SOX13抗體
Anti-PROK1/PRK1/EG-VEGF 內(nèi)分泌腺衍生血管內(nèi)皮生長(zhǎng)因子抗體
Anti-VEGF-A 血管內(nèi)皮生長(zhǎng)因子A抗體
Anti-SLITRK4 神經(jīng)突觸相關(guān)蛋白SLITRK4抗體
Anti-VEGF 血管內(nèi)皮生長(zhǎng)因子抗體
Anti-TUBA4A 微管蛋白4α抗體
Anti-VEGF 血管內(nèi)皮生長(zhǎng)因子抗體
Anti-phospho-GATA3(Ser115) 磷酸化GATA結(jié)合蛋白3抗體
Anti-VDAC 等電壓依賴性陰離子通道抗體
Anti-GDF7 生長(zhǎng)分化因子7抗體